A detailed analysis of the global progression of the pandemic, and of government’s responses, prepared by the global strategic advisory and commercial diplomacy firm, Albright Stonebridge Group. Key Takeaways According to PAHO, it is possible that countries in Central America, including Nicaragua, El Salvador, and Guatemala, will see an acceleration in outbreaks over the coming weeks. This week U.K. regulators authorized Gilead Science’s antiviral drug remdesivir for use on COVID-19 patients. An international clinical trial found that it reduced the median recovery period of COVID-19 patients in the hospital from 15 to 11 days Countries are launching campaigns to encourage domestic tourism and considering “tourism bubbles,” which would allow some countries to band together to ease travel restrictions. The European Commission […]
Policy idea: “tourism bubbles”; new outbreaks in Central America in coming weeks; Santiago’s ICU at 96% capacity. The ASG global COVID-19 update
To read this post, you must purchase a Business Intelligence Subscription, Business Intelligence - 3 to 9 User Subscription, Business Intelligence - 10+ User Subscription, Insight - 1 Month Subscription, Insight - 3 Month Subscription, Insight - 6 Month Subscription, Insight - 12 Month Subscription, Suscripción de inteligencia de negocios, Inteligencia de negocios - Suscripción de 3 a 9 usuarios or Inteligencia de negocios - Suscripción de más de 10 usuarios.
Previous article
Next article
